17.45
-0.75(-4.12%)
Currency In USD
| Previous Close | 18.2 |
| Open | 18.5 |
| Day High | 18.5 |
| Day Low | 16.16 |
| 52-Week High | 18.9 |
| 52-Week Low | 8.65 |
| Volume | 3.16M |
| Average Volume | 1.55M |
| Market Cap | 1.71B |
| PE | -109.06 |
| EPS | -0.16 |
| Moving Average 50 Days | 14.65 |
| Moving Average 200 Days | 13.53 |
| Change | -0.75 |
If you invested $1000 in ARS Pharmaceuticals, Inc. (SPRY) since IPO date, it would be worth $698 as of July 01, 2025 at a share price of $17.45. Whereas If you bought $1000 worth of ARS Pharmaceuticals, Inc. (SPRY) shares 3 years ago, it would be worth $4,235.44 as of July 01, 2025 at a share price of $17.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
May 27, 2025 12:00 PM GMT
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to
ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as little as $25 (if eligible) in preparation for summer
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 05, 2025 12:00 PM GMT
SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphy